Fundamentals-based quality & risk · not a recommendation
JALAN scores 30/100 (Avoid) on the Orion Score — poor business quality (26), poor growth (14) and moderate balance-sheet safety (55). A fundamentals-based quality & risk score, not a buy/sell recommendation.
Risk checks
Forensic accounting
Piotroski F = fundamental health (0–9, higher is better) · Altman Z = bankruptcy / distress risk · Beneish M = earnings-manipulation check
Technical / Momentum
Price Trend
—/100
Technical momentum companion — separate from the fundamentals-based Orion Score.
Unlock with Pro
Upgrade →Revenue & Profit in ₹ Crores (Yearly)
| Year | Revenue | Net Profit | EBITDA | OPM |
|---|---|---|---|---|
| FY 2025 | ₹0.79 | ₹-1.88 | ₹0.54 | -50.6% |
| FY 2024 | ₹5.37 | ₹-15.62 | ₹-14.75 | -3.7% |
| FY 2023 | ₹9.7 | ₹-13.21 | ₹-11.52 | 7.9% |
| FY 2022 | ₹5.92 | ₹-14.16 | ₹-11.87 | -77.5% |
All values in ₹ Crores
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total Assets | ₹0.52 | ₹8.52 | ₹26.26 | ₹33.07 |
| Equity | ₹-41.9 | ₹-40.02 | ₹-24.4 | ₹-11.2 |
| Total Debt | ₹35.11 | ₹40.09 | ₹42.05 | ₹28.1 |
| Cash | ₹0.01 | ₹-0.04 | ₹0.02 | ₹0.27 |
| Net Debt | ₹35.1 | ₹40.13 | ₹42.03 | ₹27.84 |
| Working Capital | ₹-36.74 | ₹-42.32 | ₹-27.52 | ₹-15.23 |
Q2 FY2026
Quarter-over-Quarter Trend
| Quarter | Promoter | FII | DII | Public |
|---|---|---|---|---|
| Q2 FY2026 | 21.58% ↓ | — | 0.19% ↑ | 78.23% ↑ |
| Q4 FY2025 | 27.65% ↓ | — | 0% | 72.35% ↑ |
| Q2 FY2025 | 27.9% ↓ | — | 0% ↓ | 72.1% ↑ |
| Q4 FY2024 | 39.66% | — | 0.17% ↑ | 60.18% ↓ |
| Q2 FY2024 | 39.66% ↓ | — | 0% | 60.34% ↑ |
| Q4 FY2023 | 39.99% ↓ | — | 0% | 60.01% ↑ |
| Q2 FY2023 | 46.22% ↓ | — | 0% | 53.78% ↑ |
| Q4 FY2022 | 50.41% | — | 0% | 49.59% |
No recent corporate actions
Ask: "Is JALAN stock a good buy right now?" — Get RSI, MACD, ROCE + AI recommendation
Analyse with OrionGet free stock analysis, market insights, and investment ideas delivered to your inbox.
No spam. Unsubscribe anytime.